Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers March 26, 2017
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - March 26, 2017

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

3/19/17 - 'Taking Primodos caused me lifetime of regret': The story of mother Marie Lyon
Mother Marie Lyon, who was prescribed Primodos and later gave birth to a daughter whose limbs were not all fully formed, describes for Sky News her painful fight for the truth... ::Sky News to expose pharmaceutical cover-up. The two tablets were called Primodos, a hormone pregnancy test manufactured by the drug company Schering, now Bayer.
3/19/17 - A tougher FDA policing
The country's Food and Drugs Administration came out last week with a warning to the public against buying certain cosmetic products. The FDA issued a public advisory on the list of these products apparently being peddled in the informal markets like neighborhood sari-sari stores all around the country. According to the FDA advisory, the products m
3/19/17 - Analyses Of PCSK9 Inhibitor Prescription Rejection Rates Demonstrate Significant Access Barriers For Appropriate Patients
Amgen today announced new data from two studies that showed that for appropriate patients in the U.S., the majority of prescription claims for PCSK9 inhibitors, such as Repatha , were initially rejected. The studies were presented at the American College of Cardiology 66 th Annual Scientific Session. In a retrospective study presented today as
3/19/17 - AstraZeneca to partner with respiratory drug company
AstraZeneca has entered into astrategic collaboration with Circassia Pharmaceuticals plc, a respiratory biopharmaceutical company, for the development and commercialisation ofTudorzaandDuaklirin the U.S.. AstraZeneca will receive a minority equity stake in Circassia. AstraZeneca will complete ongoing development activities and continue to...
3/19/17 - AstraZeneca's CVD-REAL Study Shows SGLT-2 Inhibitors Significantly Reduced Hospitalizations for Heart Failure and Death versus Other Type-2 Diabetes Medicines
AstraZeneca today announced results of the first large real-world evidence study of its kind evaluating the risk of hospitalization for heart failure and death from any cause in patients with type-2 diabetes receiving treatment with a newer class of diabetes medicines, SGLT-2 inhibitors. Bruce Cooper, MD, Vice President and Head of Global Medical A
3/19/17 - Chattanooga company among top clinical test facilities for new medicines [Chattanooga Times Free Press, Tenn.]
Dr. Krause retired from his own medical practice more than a decade ago, but the drug trial and testing business he started in 1996 ClinSearch has grown into Chattanooga's biggest clinical drug trial business. Krause has been a medical pioneer of sorts in Chattanooga since he came to town in 1977 as one of the city's first gastroenterologists a
3/19/17 - Findings from E. Burmeister Getz et al Has Provided New Information about Clinical Trials and Studies (Between-Batch Pharmacokinetic Variability...
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Investigators discuss new findings in Clinical Research- Clinical Trials and Studies. According to news reporting from Berkeley, California, by NewsRx journalists, research stated, "We previously demonstrated pharmacokinetic differences among manufacturing batches of a US Food
3/19/17 - Hashtag helps Egyptians find and donate life-saving medicines [Gulf News (United Arab Emirates)]
Cairo: Since November, Abdul Fattah Mahmoud has faced a virtually life-threatening problem. Even though, I cannot find it easily at pharmacies, "Mahmoud, an ex-school inspector, told Gulf News. Egypt has seen shortages of pharmaceuticals since November when the government free-floated the local pound as part of tough measures to reform the ailing e
3/19/17 - Link between vitamin D treatment and autism prevention [Emirates News Agency (WAM) (United Arab Emirates)]
BRISBANE, 19th March, 2017 Giving vitamin D supplements to mice during pregnancy prevents autism traits in their offspring, Australia's University of Queensland researchers have discovered. The discovery provides further evidence of the crucial role vitamin D plays in brain development, said lead researcher Professor Darryl Eyles at the universit
3/19/17 - Mamnoon for provision of affordable treatment to public
President Mamnoon Hussain on Friday emphasized the need of coordination among the physicians, pharmaceutical manufacturers and regulatory authorities to ensure the provision of affordable treatment and medicines to the public. He was talking to a delegation of Ombudsman Medicine Committee led by Federal Ombudsman Mohammad Salman Farooqi in...
3/19/17 - Marathon offloads $89K muscular dystrophy drug after pricing uproar
CHICAGO Marathon Pharmaceuticals is ready for its turn as the poster child for high drug prices to be over. Following weeks of anger from patient advocates and members of Congress, the company announced Thursday morning that it plans to sell its $89,000- a-year Duchenne muscular dystrophy drug to PTC Therapeutics, a South Plainfield, N.J., compa
3/19/17 - MiMedx Announces The Addition Of Luis A. Aguilar To Its Board Of Directors
MiMedx Group, Inc., the leading regenerative medicine and biopharmaceutical company utilizing human placental tissue allografts and patent-protected processes to develop and market advanced products and therapies for multiple sectors of healthcare, announced today its Board of Directors has appointed Luis A. Aguilar, former Commissioner of the U.
3/19/17 - Premises of a pharmaceutical company raided in AJK on complaints and declaration of substandard drugs - Press Note issued by Press Information Department
Following is the text of press note issued by Press Information Department. Drug Regulatory Authority of Pakistan is committed to provide safe effective and quality medicine with rational use and prescribing practices and there will be no compromise on quality of medicine. Director National Biological Laboratory, Additional Director QA and Federal
3/19/17 - President for close cooperation among physicians, pharmaceutical companies, regulatory institutions
President Mamnoon Hussain Friday underscored the need for unanimity on important issues regarding close cooperation among physicians, pharmaceutical companies and regulatory institutions and said in this regard Aiwan-e-Sadr would extend cooperation to the departments concerned. The committee has been constituted by Wafaqi Mohtasib and is headed...
3/19/17 - President stresses provision of affordable treatment, medicines to people
President Mamnoon Hussain has emphasized the need of coordination among the physicians, pharmaceutical manufacturers and regulatory authorities to ensure the provision of affordable treatment and medicines to the public. He was talking to a delegation of Ombudsman Medicine Committee led by Federal Ombudsman Mohammad Salman Farooqi in Islamabad on..
3/19/17 - WHO report is 'major step forward' in fight against drug-resistant bacteria
By a News Reporter-Staff News Editor at VerticalNews Health& Science A new report by the World Health Organization lays out, for the first time, which antibiotic-resistant bacteria pose the greatest risk to global health and urgently need new effective treatments. Evelina Tacconelli, executive committee member of the European Society of Clinical.
3/18/17 - A front seat for the fight against AIDS [Star-News, Wilmington, N.C.]
March 18 Thirty years ago on March 19, 1987, to be exact the U.S. Food and Drug Administration approved the drug Zidovudine better known as azidothymidine, or AZT for treatment of HIV, AIDS and pre-AIDS illnesses. Wilmington resident Joseph Bigley knows this story firsthand. He supervised clinical trials on AZT as an employee of the famed
3/18/17 - Akari Therapeutics Announces R&D Day on April 24, 2017 [T-break Tech (Middle East)]
-Akari Therapeutics, an emerging growth, clinical-stage biopharmaceutical company, announced today that it will hold a Research and Development Day on April 24, 2017 in New York. Results from the pre-clinical development program targeting new disease opportunities for our lead compound Coversin, focusing on its unique dual leukotriene B4/ C5 activi
3/18/17 - Ampio Receives Guidance from the FDA and Proposes a Path for Approval for Single-Injection Ampion for the Treatment of Pain Due to Severe...
Ampio Receives Guidance from the FDA and Proposes a Path for Approval for Single-Injection Ampion for the Treatment of Pain Due to Severe Osteoarthritis of the Knee. By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Ampio Pharmaceuticals, Inc. announced that the Office of Tissue and Advanced Therapies, a branch of the Center
3/18/17 - Automated External Defibrillator Market Confident That Rise of Remote Healthcare Will Open New Growth Opportunities - MarketIntelReports
The report Global Automated External Defibrillator Market by Manufacturers, Regions, Type and Application, Forecast to 2022, available on MarketIntelReports, estimates that the prevalence of unhealthy lifestyles in countries like India will be a key future growth driver. Browse numerous Market Tables as well as Figures which are spread thro
3/18/17 - B vitamins may help reduce harm from air pollution [Philippines News Agency]
The study, led by Jia Zhong of Columbia University's Mailman School of Public Health, showed that B vitamins such as folic acid, vitamin B6 and vitamin B12 may play a critical role in reducing the impact of air pollution on a specific type of epigenetic modification called DNA methylation, which has been linked to cardiovascular disease and even ca
3/18/17 - Blood-Based Diagnostic Assay from Biodesix Measures Immunotherapy Biomarker PD-L1
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week New data from Biodesix evaluating an assay in development demonstrated the potential to measure circulating PD-L1 through mRNA in blood through multiplexed droplet digital? PCR detection. The assay uses proprietary RNA isolation methods consistent with Biodesix's...
3/18/17 - Business Group Makes Price Recommendations for Specialty Drugs [Sudan Tribune]
As specialty drugs become more prevalent, the costs associated with them must be lowered, according to a report from the National Business Group on Health. Their report, Policy Recommendations to Promote Sustainable, Affordable Pricing for Specialty Pharmaceuticals details how and why specialty drugs are increasing in price, and how those prices mi
3/18/17 - Chinese pharma firms target the global market [Sudan Tribune]
WALK into the Shanghai laboratories of Chi-Med, a biotech firm, and you encounter the sort of shiny, cutting-edge facilities common in any major pharma company in America, Europe or Japan. If the drug is approved both in China and in Western markets it could be the very first prescription drug to be designed and developed entirely in China that wil
3/18/17 - Cholesterol drug cuts heart risks, spurs new debate on cost Cholesterol drug cuts heart risks, spurs new debate on cost Cholesterol drug cuts heart risks, spurs new debate on cost A long-acting cholesterol medicine cut the risk of having a heart atta
A long-acting cholesterol medicine cut the risk of having a heart attack or some other serious problems by 15 to 20 percent in a big study that's likely to spur fresh debate about what drugs should cost. It costs more than $14,000 a year, and insurers have balked at paying without proof that it lowers heart risks, not just the cholesterol number.
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415